| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
88,862 |
80,146 |
$3.49M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,805 |
3,386 |
$1.09M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,432 |
5,293 |
$1.00M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,095 |
18,745 |
$904K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,816 |
7,589 |
$862K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
6,107 |
5,035 |
$521K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
24,387 |
21,007 |
$506K |
| 80053 |
Comprehensive metabolic panel |
42,440 |
38,253 |
$488K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17,683 |
15,593 |
$487K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,761 |
4,656 |
$457K |
| 99199 |
Unlisted special service, procedure or report |
9,186 |
8,225 |
$408K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
43,690 |
39,199 |
$335K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,701 |
5,417 |
$334K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,984 |
3,905 |
$317K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,202 |
2,155 |
$304K |
| 71045 |
Radiologic examination, chest; single view |
22,694 |
21,431 |
$304K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,790 |
2,635 |
$300K |
| 0121 |
|
224 |
203 |
$296K |
| Z7502 |
|
7,060 |
6,975 |
$255K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,152 |
1,125 |
$179K |
| 84484 |
|
17,223 |
10,711 |
$170K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,427 |
2,278 |
$167K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,224 |
3,129 |
$159K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,895 |
7,230 |
$142K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
22,881 |
18,233 |
$125K |
| 85610 |
|
27,890 |
25,849 |
$120K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,172 |
3,043 |
$118K |
| 83690 |
|
16,982 |
15,841 |
$108K |
| 0270 |
|
19,630 |
10,787 |
$108K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,757 |
11,790 |
$105K |
| 0250 |
|
35,814 |
18,282 |
$101K |
| 93971 |
|
1,129 |
1,112 |
$101K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
6,758 |
1,827 |
$101K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,866 |
1,820 |
$99K |
| J3490 |
Unclassified drugs |
24,014 |
14,162 |
$92K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,571 |
1,563 |
$91K |
| 76830 |
Ultrasound, transvaginal |
1,529 |
1,487 |
$84K |
| 83880 |
|
3,680 |
3,521 |
$83K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,280 |
3,152 |
$80K |
| 83735 |
|
12,212 |
11,086 |
$79K |
| 84703 |
|
12,978 |
12,039 |
$78K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,341 |
5,197 |
$72K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,062 |
1,974 |
$68K |
| 81001 |
|
13,617 |
12,970 |
$64K |
| 87631 |
|
1,345 |
1,333 |
$63K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,666 |
1,606 |
$60K |
| 76801 |
|
1,416 |
1,254 |
$59K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,361 |
1,205 |
$59K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,177 |
10,209 |
$58K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
586 |
575 |
$56K |
| 81003 |
|
14,185 |
13,414 |
$55K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,232 |
1,174 |
$55K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,028 |
2,850 |
$54K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,789 |
6,571 |
$52K |
| 0762 |
|
1,187 |
1,115 |
$51K |
| 71046 |
Radiologic examination, chest; 2 views |
2,543 |
2,497 |
$50K |
| 70486 |
|
401 |
394 |
$50K |
| 80305 |
|
2,930 |
2,767 |
$50K |
| 87040 |
|
4,460 |
2,789 |
$47K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,693 |
6,454 |
$47K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,679 |
6,051 |
$44K |
| 72100 |
|
1,645 |
1,632 |
$44K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,674 |
1,629 |
$43K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,669 |
1,628 |
$43K |
| 73562 |
|
2,219 |
2,020 |
$42K |
| 73610 |
|
1,888 |
1,817 |
$42K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
188 |
182 |
$41K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,841 |
2,671 |
$41K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,883 |
1,940 |
$40K |
| 87400 |
|
5,039 |
2,715 |
$37K |
| 73630 |
|
2,000 |
1,899 |
$36K |
| 96376 |
|
2,748 |
2,162 |
$36K |
| 85379 |
|
3,532 |
3,432 |
$35K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,392 |
4,163 |
$34K |
| 73030 |
|
1,641 |
1,574 |
$32K |
| 80061 |
Lipid panel |
3,019 |
2,889 |
$32K |
| 85730 |
|
6,158 |
5,947 |
$32K |
| 80329 |
|
3,093 |
1,524 |
$32K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
749 |
725 |
$32K |
| 83605 |
|
3,081 |
2,735 |
$28K |
| 73130 |
|
1,409 |
1,336 |
$28K |
| 80320 |
|
1,914 |
1,751 |
$27K |
| 0160 |
|
671 |
568 |
$26K |
| 87088 |
|
4,456 |
4,322 |
$26K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,186 |
2,857 |
$25K |
| 73110 |
|
1,063 |
1,012 |
$22K |
| 90715 |
|
786 |
779 |
$22K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,282 |
1,275 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
26,080 |
22,321 |
$21K |
| 84702 |
|
1,804 |
1,576 |
$20K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
674 |
672 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,141 |
1,771 |
$18K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
674 |
553 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,470 |
1,435 |
$17K |
| 82947 |
|
6,101 |
3,422 |
$17K |
| 87081 |
|
1,745 |
1,708 |
$17K |
| 82150 |
|
3,066 |
2,939 |
$16K |
| 87186 |
|
2,084 |
2,033 |
$15K |
| 82077 |
|
1,036 |
940 |
$13K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,379 |
3,152 |
$13K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,863 |
2,651 |
$13K |
| 72040 |
|
548 |
545 |
$13K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,259 |
2,909 |
$13K |
| 80299 |
|
1,146 |
976 |
$13K |
| 70496 |
|
57 |
55 |
$13K |
| 76642 |
|
334 |
333 |
$13K |
| 59025 |
Fetal non-stress test |
966 |
754 |
$12K |
| 87807 |
|
1,001 |
961 |
$12K |
| 70498 |
|
58 |
56 |
$12K |
| 74018 |
|
619 |
602 |
$12K |
| 0761 |
|
295 |
276 |
$11K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,331 |
1,987 |
$10K |
| 86901 |
|
3,371 |
2,606 |
$10K |
| J2060 |
Injection, lorazepam, 2 mg |
2,305 |
1,864 |
$10K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,145 |
2,966 |
$9K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
858 |
802 |
$9K |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
51 |
40 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
237 |
210 |
$9K |
| 86900 |
|
3,353 |
2,599 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,050 |
1,018 |
$8K |
| 87077 |
|
1,317 |
1,294 |
$8K |
| 73080 |
|
337 |
325 |
$8K |
| Z7610 |
|
641 |
444 |
$7K |
| 85027 |
|
1,356 |
1,117 |
$7K |
| 73590 |
|
322 |
297 |
$7K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
828 |
756 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
52 |
50 |
$7K |
| 99070 |
|
1,779 |
661 |
$7K |
| 80143 |
|
551 |
510 |
$7K |
| 29125 |
|
271 |
268 |
$7K |
| A4649 |
Surgical supply; miscellaneous |
911 |
415 |
$7K |
| 93970 |
|
40 |
39 |
$6K |
| 96367 |
|
215 |
198 |
$6K |
| 73502 |
|
217 |
216 |
$5K |
| 84145 |
|
158 |
155 |
$5K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
694 |
649 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
337 |
172 |
$5K |
| 84100 |
|
1,224 |
1,023 |
$5K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
15 |
14 |
$5K |
| 76641 |
|
98 |
98 |
$4K |
| 86850 |
|
898 |
859 |
$4K |
| 80047 |
|
267 |
260 |
$4K |
| 0710 |
|
907 |
870 |
$4K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
346 |
251 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
898 |
876 |
$4K |
| 73090 |
|
156 |
154 |
$3K |
| 90714 |
|
143 |
143 |
$3K |
| 82550 |
|
564 |
522 |
$3K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
372 |
337 |
$3K |
| 12001 |
|
38 |
38 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,064 |
911 |
$3K |
| 81025 |
|
677 |
672 |
$3K |
| 73140 |
|
210 |
209 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
549 |
421 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
40 |
39 |
$2K |
| 0301 |
|
454 |
409 |
$2K |
| 84439 |
|
213 |
206 |
$2K |
| 0324 |
|
350 |
341 |
$2K |
| 84436 |
|
351 |
328 |
$2K |
| 93017 |
|
30 |
29 |
$2K |
| 0370 |
|
54 |
54 |
$2K |
| 29515 |
|
47 |
46 |
$1K |
| 86140 |
|
327 |
318 |
$1K |
| 99000 |
|
363 |
362 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
72 |
56 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
389 |
346 |
$1K |
| 76870 |
|
27 |
25 |
$1K |
| 87147 |
|
224 |
220 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
369 |
298 |
$1K |
| 0637 |
|
667 |
511 |
$990.34 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
15 |
12 |
$958.61 |
| J3360 |
Injection, diazepam, up to 5 mg |
102 |
82 |
$950.17 |
| 86308 |
|
62 |
61 |
$935.99 |
| 0403 |
|
60 |
60 |
$859.05 |
| 97161 |
|
40 |
40 |
$846.52 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
578 |
459 |
$834.77 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
2,588 |
2,087 |
$808.17 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
496 |
451 |
$799.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
16 |
15 |
$748.17 |
| 10060 |
|
59 |
56 |
$739.20 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,015 |
976 |
$729.82 |
| 12002 |
|
58 |
54 |
$686.02 |
| 82805 |
|
30 |
29 |
$676.94 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
29 |
28 |
$614.49 |
| J2785 |
Injection, regadenoson, 0.1 mg |
13 |
12 |
$609.56 |
| 87070 |
|
90 |
87 |
$594.19 |
| 0420 |
|
75 |
39 |
$590.01 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
98 |
97 |
$553.13 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
503 |
485 |
$511.06 |
| G0378 |
Hospital observation service, per hour |
17 |
14 |
$472.89 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
52 |
39 |
$468.26 |
| J1953 |
Injection, levetiracetam, 10 mg |
32 |
24 |
$428.69 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
22 |
12 |
$415.04 |
| 0258 |
|
407 |
334 |
$408.04 |
| 0360 |
|
74 |
73 |
$394.24 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
660 |
543 |
$350.78 |
| J1630 |
Injection, haloperidol, up to 5 mg |
84 |
72 |
$326.11 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
68 |
62 |
$296.10 |
| 12011 |
|
12 |
12 |
$288.81 |
| J7510 |
Prednisolone oral, per 5 mg |
154 |
150 |
$246.78 |
| 94644 |
|
14 |
14 |
$217.66 |
| 85652 |
|
126 |
121 |
$201.62 |
| 80076 |
|
47 |
44 |
$187.59 |
| 73060 |
|
14 |
13 |
$184.62 |
| 82010 |
|
30 |
26 |
$166.98 |
| 73552 |
|
14 |
13 |
$155.32 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
81 |
26 |
$139.73 |
| 87210 |
|
54 |
51 |
$138.42 |
| 87205 |
|
26 |
25 |
$78.16 |
| J7612 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
46 |
38 |
$76.46 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
33 |
15 |
$71.41 |
| 0636 |
|
320 |
254 |
$62.56 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
12 |
12 |
$62.26 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
119 |
99 |
$62.06 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$61.84 |
| 97016 |
|
53 |
14 |
$55.16 |
| 0260 |
|
18 |
18 |
$49.60 |
| 99072 |
|
27 |
19 |
$39.54 |
| 29130 |
|
12 |
12 |
$36.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
16 |
13 |
$24.68 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
73 |
69 |
$18.40 |
| C9113 |
Injection, pantoprazole sodium, per vial |
14 |
14 |
$10.08 |
| 0305 |
|
381 |
347 |
$4.97 |
| 0302 |
|
57 |
51 |
$4.09 |
| 0307 |
|
129 |
121 |
$0.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
1,469 |
707 |
$0.00 |
| Q4051 |
Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) |
42 |
22 |
$0.00 |
| 0352 |
|
13 |
13 |
$0.00 |
| 0306 |
|
62 |
58 |
$0.00 |
| 93042 |
|
33 |
32 |
$0.00 |
| 0300 |
|
489 |
419 |
$0.00 |
| 0730 |
|
105 |
98 |
$0.00 |
| 0940 |
|
55 |
53 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
12 |
$0.00 |
| 99499 |
|
18 |
12 |
$0.00 |
| 0760 |
|
12 |
12 |
$0.00 |